Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 25 EP applications Dirk Halbig has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 18, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12799571

INHIBITORS OF HCV NS5A

IPC classification:
A61K 38/06, C07K 5/08, C07D 237/26, C07D 233/64, A61P 31/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13737175

TRIAZOLE COMPOUNDS AS ANTIVIRALS

IPC classification:
A61K 31/4196, C07D 403/12, C07D 249/14, A61P 31/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP14702466

ANTIVIRAL TRIAZOLE DERIVATIVES

IPC classification:
A61K 31/4196, C07D 401/12, C07D 249/14, A61P 31/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14707400

ANTIVIRAL COMPOUNDS

IPC classification:
A61P 31/12, A61K 31/4196, C07D 487/10, C07D 409/12, C07D 401/12, C07D 403/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14707401

ANTIVIRAL COMPOUNDS

IPC classification:
A61P 31/12, A61K 31/4196, C07D 249/14, C07D 401/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14707410

ANTIVIRAL COMPOUNDS

IPC classification:
A61P 31/00, A61K 31/4745, A61K 31/501, A61K 31/4196, A61K 31/427, A61K 31/4439, C07D 471/04, C07D 417/12, C07D 409/12, C07D 401/12, C07D 403/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP14710208

ANTIVIRAL COMPOUNDS

IPC classification:
A61K 31/12, A61K 31/4196, C07D 249/14, C07D 405/12, C07D 401/12, C07D 403/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14708234

ANTIVIRAL COMPOUNDS

IPC classification:
A61K 31/538, A61K 31/5377, A61K 31/496, A61K 31/425, A61K 31/454, A61K 31/4196, C07D 495/04, C07D 491/107, C07D 249/14, C07D 417/12, C07D 413/12, C07D 411/12, C07D 405/12, C07D 401/12, C07D 403/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14706841

N-HETEROARYL SUBSTITUTED ANILINE DERIVATIVES AS HCV-ANTIVIRALS

IPC classification:
A61P 31/12, A61K 31/4196, A61K 31/4164, C07D 271/06, C07D 263/40
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14724735

6-BRIDGED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

IPC classification:
A61P 31/12, A61K 31/506, C07D 491/18, C07D 487/08, C07D 471/08, C07D 453/06, C07D 491/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14820805

BIOMARKERS FOR HBV TREATMENT RESPONSE

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP15710127

NOVEL 6-FUSED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

IPC classification:
A61P 31/12, C07D 513/04, C07D 498/04, A61K 31/4985, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15766159

STABLE, BENZYL ALCOHOL-FREE AQUEOUS SOLUTION FORMULATIONS CONTAINING ALPHA-TYPE INTERFERON

IPC classification:
A61K 47/60, A61K 47/26, A61K 47/18, A61K 47/10, A61K 38/21, A61K 9/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15813759

BIOMARKERS FOR HBV TREATMENT RESPONSE

IPC classification:
C12Q 1/70, C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16700562

PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES

IPC classification:
A61P 31/12, A61K 31/519, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP16728524

HUMANIZED ANTI-EBOLA VIRUS GLYCOPROTEIN ANTIBODIES AND METHODS OF USE

IPC classification:
C12N 15/09, C07K 16/08, A61K 39/42
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16747742

BIOMARKERS FOR HBV TREATMENT RESPONSE

IPC classification:
C12Q 1/70, C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17165654

PEPTIDE MACROCYCLES AND USE THEREOF IN THE TREATMENT OF BACTERIAL INFECTIONS

IPC classification:
A61P 31/00, A61K 38/06, C07D 471/08, C07D 403/06, C07K 5/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
The application has been published
EP17165651

ANTI-BACTERIAL PEPTIDE MACROCYCLES AND USE THEREOF

IPC classification:
A61P 31/04, A61K 38/00, C07K 5/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
The application has been published
EP17705612

PROCESS FOR THE PREPARATION OF 4-PHENYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDIN-6-YL]METHYL]-3-OXO-5,6,8,8A-TETRAHYDRO-1H-IMIDAZO[1,5-A]PYRAZIN-2-YL]-CARBOXYLIC ACID

IPC classification:
C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17724043

NOVEL PYRAZINE COMPOUNDS WITH OXYGEN, SULFUR AND NITROGEN LINKER FOR THE TREATMENT OF INFECTIOUS DISEASES

IPC classification:
A61P 31/20, A61K 31/4985, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17734699

PYRIDAZINONE-BASED BROAD SPECTRUM ANTI-INFLUENZA INHIBITORS

IPC classification:
A61P 31/16, A61K 31/502, C07D 491/052, C07D 471/04, C07D 405/12, C07D 401/12, C07D 403/12, C07D 401/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17737571

6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE AND 6,7-DIHYDRO-4H-TRIAZOLO[1,5-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES

IPC classification:
A61K 31/542, A61K 31/541, A61K 31/5383, A61K 31/4985, C07D 513/04, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17739241

NOVEL TETRAHYDROPYRAZOLOPYRIDINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES

IPC classification:
A61K 31/444, A61K 31/5377, A61K 31/437, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17737570

CARBOXY 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES

IPC classification:
A61P 31/12, A61K 31/4995, A61K 31/4985, C07D 487/08, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dirk Halbig, F. Hoffmann-La Roche AG
Status:
Request for examination was made

Please Sign in to use this feature